91 related articles for article (PubMed ID: 12094875)
1. Cirrhosis does not shift the circadian phase of plasma fibrinolysis.
Piscaglia F; Hermida RC; Siringo S; Legnani C; Ramadori G; Bolondi L
Am J Gastroenterol; 2002 Jun; 97(6):1512-7. PubMed ID: 12094875
[TBL] [Abstract][Full Text] [Related]
2. Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices.
Piscaglia F; Siringo S; Hermida RC; Legnani C; Valgimigli M; Donati G; Palareti G; Gramantieri L; Gaiani S; Burroughs AK; Bolondi L
Hepatology; 2000 Feb; 31(2):349-57. PubMed ID: 10655257
[TBL] [Abstract][Full Text] [Related]
3. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
[TBL] [Abstract][Full Text] [Related]
4. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
5. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
6. [Regulators of fibrinolysis in chronic viral pathology of the liver].
Iagoda AV; Koroĭ PV
Ter Arkh; 2009; 81(2):50-4. PubMed ID: 19334490
[TBL] [Abstract][Full Text] [Related]
7. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
8. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
[TBL] [Abstract][Full Text] [Related]
9. [Changes in the 24-hour rhythm of plasma melatonin in patients with liver cirrhosis--relation to sleep architecture].
Steindl PE; Finn B; Bendok B; Rothke S; Zee PC; Blei AT
Wien Klin Wochenschr; 1997 Oct; 109(18):741-6. PubMed ID: 9441518
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
[TBL] [Abstract][Full Text] [Related]
11. Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies.
Macy EM; Meilahn EN; Declerck PJ; Tracy RP
Arch Pathol Lab Med; 1993 Jan; 117(1):67-70. PubMed ID: 8418765
[TBL] [Abstract][Full Text] [Related]
12. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
[TBL] [Abstract][Full Text] [Related]
13. [Activation of fibrynolysis in children with chronic B or C hepatitis].
Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
[TBL] [Abstract][Full Text] [Related]
14. Effects of the mineralocorticoid fludrocortisone on fibrinolytic function in healthy subjects.
Lottermoser K; Hertfelder HJ; Wehling M; Schiermeyer B; Vetter H; Düsing R
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):357-60. PubMed ID: 11967823
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
[TBL] [Abstract][Full Text] [Related]
17. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
Pasqualetti P; Casale R
Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
[TBL] [Abstract][Full Text] [Related]
18. [Changes of plasma fibrinolysis system and the effect of captopril in high altitude pulmonary edema].
Yu J; Li DS; Lei YQ; Ba HL; Fu ZM; Li SD; Hou TC; Peng CL
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Sep; 26(9):552-4. PubMed ID: 14521760
[TBL] [Abstract][Full Text] [Related]
19. High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding.
Primignani M; Dell'Era A; Bucciarelli P; Bottasso B; Bajetta MT; de Franchis R; Cattaneo M
Dig Liver Dis; 2008 Nov; 40(11):874-81. PubMed ID: 18329968
[TBL] [Abstract][Full Text] [Related]
20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
